Medical Therapy of Perianal Crohn's Disease

被引:8
作者
Klag, Thomas [1 ]
Goetz, Martin [1 ]
Stange, Eduard F. [2 ]
Wehkamp, Jan [1 ]
机构
[1] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany
[2] Robert Bosch Krankenhaus, Dept Internal Med 1, Stuttgart, Germany
来源
VISZERALMEDIZIN | 2015年 / 31卷 / 04期
关键词
Inflammatory bowel disease; Crohn's disease; Perianal fistula; Anti-TNF-alpha therapy; Crohn's disease complications;
D O I
10.1159/000434664
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Development of perianal fistulas are a common feature of Crohn's disease (CD). Consequences are severe impairment of quality of life as well as potentially life-threatening complications like abscess formation or bacterial sepsis. Therefore, appropriate treatment is an important task in the management of CD. Methods: This review describes the epidemiology, pathogenesis, diagnosis, and conservative medical treatment of perianal CD with regard to the available literature. In February 2015, a PubMed search was performed with the following terms (combined and separate): 'Crohn's disease management', 'Crohn's disease complications', 'perianal Crohn's disease', 'fistulizing Crohn's disease', 'perianal fistulas', 'fistula healing', 'fistula closure'. From the search results, 36 articles were chosen as core elements of this review. Results: Pelvic magnetic resonance imaging and rectal endosonography are established diagnostic approaches to evaluate perianal fistulas in conjunction with endoscopy. Antibiotics, thiopurines, and calcineurin inhibitors are useful agents in the management of perianal CD. The availability of anti-TNF-alpha therapies has substantially changed the prospects and goals of medical treatment, and fistula healing seems to be possible in a substantial proportion of patients. Conclusion: Antibiotics and several immunosuppressive drugs have improved the treatment of fistulizing CD and should be combined with surgical measures. (C) 2015 S. Karger GmbH, Freiburg
引用
收藏
页码:265 / 272
页数:8
相关论文
共 57 条
[1]   Thiopurines in inflammatory bowel disease revisited [J].
Baer, Florian ;
Sina, Christian ;
Fellermann, Klaus .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (11) :1699-1706
[2]   Morphological characterisation of Crohn's disease fistulae [J].
Bataille, F ;
Klebl, F ;
Rümmele, P ;
Schroeder, J ;
Farkas, S ;
Wild, PJ ;
Fürst, A ;
Hofstädter, F ;
Schölmerich, J ;
Herfarth, H ;
Rogler, G .
GUT, 2004, 53 (09) :1314-1321
[3]  
BERNSTEIN LH, 1980, GASTROENTEROLOGY, V79, P357
[4]  
BRANDT LJ, 1982, GASTROENTEROLOGY, V83, P383
[5]   Review article: medical therapy for fistulizing Crohn's disease [J].
Bressler, B. ;
Sands, B. E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (09) :1283-1293
[6]   Clinical examination, endosonography, and MR imaging in preoperative assessment of fistula in ano: Comparison with outcome-based reference standard [J].
Buchanan, GN ;
Halligan, S ;
Bartram, CI ;
Williams, AB ;
Tarroni, D ;
Cohen, CRG .
RADIOLOGY, 2004, 233 (03) :674-681
[7]   Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial [J].
Colombel, Jean-Frederic ;
Sandborn, William J. ;
Rutgeerts, Paul ;
Enns, Robert ;
Hanauer, Stephen B. ;
Panaccione, Remo ;
Schreiber, Stefan ;
Byczkowski, Dan ;
Li, Ju ;
Kent, Jeffrey D. ;
Pollack, Paul F. .
GASTROENTEROLOGY, 2007, 132 (01) :52-65
[8]   Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease [J].
Dejaco, C ;
Harrer, M ;
Waldhoer, T ;
Miehsler, W ;
Vogelsang, H ;
Reinisch, W .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) :1113-1120
[9]   Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI) [J].
Dewint, Pieter ;
Hansen, Bettina E. ;
Verhey, Elke ;
Oldenburg, Bas ;
Hommes, Daniel W. ;
Pierik, Marieke ;
Ponsioen, Cyriel I. J. ;
van Dullemen, Hendrik M. ;
Russel, Maurice ;
van Bodegraven, Ad A. ;
van der Woude, C. Janneke .
GUT, 2014, 63 (02) :292-299
[10]   Mechanisms and modulation of intestinal epithelial repair [J].
Dignass, AU .
INFLAMMATORY BOWEL DISEASES, 2001, 7 (01) :68-77